Parathyroid Hormone and Heart Failure: Novel Biomarker Strategy

E-ISSN： 2212-3873|13|1|100-104

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.13, Iss.1, 2013-03, pp. : 100-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Growth hormone therapy in heart failure: a novel therapy worthy of further consideration?

By Demers Catherine McKelvie Robert S

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 8, 2005-08 ,pp. : 1009-1018

Informa Healthcare

Access to resources Recommend Favorite

The Roles of Parathyroid Hormone and Calcitonin in Bone Remodeling: Prospects for Novel Therapeutics

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 1, 2006-03 ,pp. : 59-76

Bentham Science Publishers

Access to resources Recommend Favorite

Novel pharmacological treatments for heart failure

By Tang WH Wilson Francis Gary S

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 11, 2003-11 ,pp. : 1791-1801

Informa Healthcare

Access to resources Recommend Favorite

Growth hormone and testosterone in heart failure therapy

By Agarwal Megha Naghi Jesse Philip Kiran Phan Anita Willix Jr Robert D Schwarz Ernst R

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 11, 2010-08 ,pp. : 1835-1844

Informa Healthcare

Access to resources Recommend Favorite

Growth hormone, vascular reactivity, and heart failure

By Napoli Raffaele

European Journal of Clinical Pharmacology, Vol. 62, Iss. 1, 2006-02 ,pp. : 141-144

Springer Publishing Company

Access to resources Recommend Favorite